Cutler Group LP Catalent, Inc. Put Options Transaction History

Cutler Group LP

9 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q1 2024 Apr 19, 2024	BUY	$42.56 - $59.82 $4,256 - $5,982	100 New	100 $0
Q3 2023 Nov 07, 2023	BUY	$44.2 - $50.2 $331,500 - $376,500	7,500 Added 40.11%	26,200 $17,000
Q2 2023 Jul 18, 2023	BUY	$31.86 - $67.26 $509,760 - $1.08 Million	16,000 Added 592.59%	18,700 $4,000
Q1 2023 May 01, 2023	BUY	$45.44 - $74.26 $122,688 - $200,502	2,700 New	2,700 $10,000
Q2 2022 Aug 04, 2022	SELL	$87.2 - $114.05 $174,400 - $228,100	-2,000 Closed	0 $0
Q1 2022 Apr 14, 2022	BUY	$94.19 - $124.49 $37,676 - $49,796	400 Added 25.0%	2,000 $54,000
Q3 2021 Oct 26, 2021	BUY	$109.17 - $142.35 $174,672 - $227,760	1,600 New	1,600 $30,000
Q1 2021 Apr 26, 2021	SELL	$101.51 - $125.27 $253,775 - $313,175	-2,500 Closed	0 $0
Q4 2020 Jan 21, 2021	BUY	$85.88 - $105.36 $214,700 - $263,400	2,500 New	2,500 $4,000

514

149M

575K

2.03M

Ticker CTLT
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 179,896,000
Market Cap $11.4B
Description
Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

Stay updated on Cutler Group LP with notifications on news.